Apdm Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 1.08 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.50 Cr
About Apdm Pharmaceuticals
Apdm Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 2022 (Two years and seven months 25 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.08 M.
The company currently has active open charges totaling ₹37.50 Cr.
Jaishree Sharma, Mousumi Mandal, and Jayanta Mandal serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2022PTC132956
-
Company No.
132956
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jun 2022
-
Date of AGM
21 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Apdm Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaishree Sharma
|
Director | 16-Jun-2022 | Current |
|
Mousumi Mandal
|
Director | 16-Jun-2022 | Current |
|
Jayanta Mandal
|
Director | 16-Jun-2022 | Current |
Financial Performance of Apdm Pharmaceuticals.
Apdm Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apdm Pharmaceuticals?
Unlock access to Apdm Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Celestis Pharmaceuticals Private LimitedMousumi Mandal is a mutual person
-
Janus Scientific LlpJaishree Sharma is a mutual person
-
Jsm Innovations Llp
Mousumi Mandal and Jayanta Mandal are mutual person
Charges (Loans)
₹37.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 37.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2024 | Others | ₹37.50 Cr | Open |
How Many Employees Work at Apdm Pharmaceuticals?
Unlock and access historical data on people associated with Apdm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apdm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apdm Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.